Skip to content

Psychedelic-assisted therapy: all studies

Page 252 of 294: studies 2,511 to 2,520 of 2,936, newest first. Back to the psychedelic-assisted therapy overview

Research

SPECIAL ISSUE: Do Biofeedback, Neurofeedback, and Neuromeditation Have a Role in Psychedelic-Assisted Therapies?

Biofeedback 2022 Jeff Tarrant

“Are magic mushrooms the miracle cure for depression we've been looking for?” (Khan, 2021). Attention-grabbing headlines such as this are becoming increasingly common and suggest that psychedelic medicines are some kind of magic bullet. This perception is increased by stories of people who had a single life-changing psychedelic experience that resulted in complete relief of their long-standing...

Psychedelic psychotherapy and the cultural concept of the person

eScholarship@McGill 2022 Khaleel Rajwani

Despite the culturally diverse history of psychedelics, dominant cultural assumptions constrain emerging psychedelic healing practices and therapeutic models in contemporary Western biomedical practice. I draw on Kirmayer’s “Psychotherapy and the Cultural Concept of the Person” (2007) to discuss how the emerging model of psychedelic psychotherapy inherits the egocentric cultural concept of self...

Uso terapêutico de mdma na psicoterapia assistida para o tratamento de transtorno de estresse pós-traumático (tept)

2022 Amanda Medeiros Furquim, Tânia Marcourakis

INTRODUÇÃO: O Transtorno de Estresse Pós-Traumático (TEPT) é um transtorno neuropsiquiátrico que se desencadeia após a experiência ou testemunho de um evento psicologicamente traumático. Este distúrbio representa um grande problema de saúde pública mundial, afetando mais de 8 milhões de americanos e custando cerca de US{dollar} 43,2 bilhões por ano aos EUA. Os tratamentos existentes consistem...

DOI: 10.11606/003101848 (opens in new tab) Full text (opens in new tab) MDMA Drug administration Psychotherapist Gynecology

Psicoterapia assistida por psilocibina no tratamento da depressão

2022 Gabriela Zorzi Marcello Marcello, Tânia Marcourakis

A depressão é uma doença que acomete cerca de 3,4% da população mundial e para a qual, até hoje, existem diversas barreiras para que se possa alcançar a cura. Os tratamentos atuais baseiam-se em medicação antidepressiva, sendo de primeira escolha, na maior parte dos casos, a classe dos inibidores seletivos da recaptação de serotonina (ISRS). No cenário de utilização da farmacoterapia com...

DOI: 10.11606/003103379 (opens in new tab) Full text (opens in new tab) Medline Perspective graphical Psychic Clinical practice +1

What Conceptual Metaphors Appear in Texts on Psychedelics and Medicine? Corpus-Based Cognitive Study

Respectus Philologicus 2022

This paper aims to present conceptual metaphors employed to discuss psychedelics in texts published online by organizations popularizing knowledge about psychedelic substances. The foundation of this investigation comprises Cognitive Grammar, Conceptual Metaphor Theory, and Corpus Linguistics. A corpus of 160 texts on medical research, mental health, and therapy published in 2020 is built to...

Presence, Trust, and Empathy: Preferred Characteristics of Psychedelic Carers

Journal of Humanistic Psychology 2022

Research into psychedelic-assisted psychotherapy (PAP) is rapidly increasing with best practice guidelines being continuously updated. Yet the key principals of such guidelines are based on evidence accumulated during earlier research into these treatments and trans-disciplinary psychotherapeutic knowledge. One area of practice-based evidence that has not been considered is that accumulated by...

Case report: Medical student types journals during ketamine infusions for suicidal ideation, treatment-resistant depression, post-traumatic stress disorder, and generalized anxiety disorder.

Frontiers in Psychiatry 2022 Joshua Willms, Ben McCauley, Lindsay Kerr et al.

Suicide is the most common cause of death in male resident physicians and the second most common cause of death in resident physicians overall. Physicians also experience high rates of major depressive disorder (MDD), post-traumatic stress disorder (PTSD), and burnout. These conditions frequently develop during medical school, and threaten not only physicians but the patients they care for. A...

DOI: 10.3389/fpsyt.2022.1020214 (opens in new tab) Full text (opens in new tab) Depression Ketamine assisted psychotherapy Medical school Suicidality

The age of psychedelics

Journal of Psychopharmacology 2022 A. H. Young 3 citations

The 21st century has seen a dramatic flow and ebb in the fortunes of clinical psychopharmacology particularly with regard to antidepressants. For about 20 years, perhaps from about 1985 onwards, the tide flowed in with many ‘new’ drugs being made available to clinicians. In mood and psychotic disorders, these were essentially incremental advances from old drugs such as amitriptyline and...

Lysergic Acid Diethylamide Produces Anxiogenic Effects in the Rat Light/Dark Test and Elevated Plus Maze

Psi Chi Journal of Psychological Research 2022 Catherine N. Conway, Lisa E Baker 6 citations

Recent clinical trials indicate favorable therapeutic outcomes of psychedelic-assisted psychotherapy for anxiety and treatment-resistant depression. Whereas the neurobiological systems underlying these effects are not well understood, animal behavioral models can serve to investigate these mechanisms. For the current study, we implemented 2 rodent models predictive of anxiolytic drug effects, a...

Psicoterapia auxiliada por MDMA como tratamento do transtorno de estresse pós-traumático

2022 Davi Mello Castanheira, Andréa da Silva Torrão

INTRODUÇÃO: O Transtorno de Estresse Pós-Traumático (TEPT) é definido como uma condição na qual um indivíduo que sofreu um evento traumático revisita a experiência na forma de lembranças, sonhos ou episódios dissociativos de flashback. A psicoterapia é considerada como primeira opção para o tratamento de TEPT, mas também se utiliza a farmacoterapia com os ISRS paroxetina e sertralina. Os...

DOI: 10.11606/003102989 (opens in new tab) Full text (opens in new tab) MDMA Clinical practice Clinical treatment Psychotherapist +1